Interleukin-6 (IL-6) is a single-chain glycoprotein encoded by the gene on chromosome 7p21. It is composed of 184 amino acids in its mature segment. Structurally, it belongs to the four-helix bundle cytokine family, featuring four anti-parallel α-helices stabilized by two internal disulfide bonds.
To initiate cellular signaling, IL-6 binds to its specific ligand-binding receptor, IL-6R (CD126). This initial pairing recruits a second transmembrane protein, gp130 (CD130), which acts as the universal signaling subunit for the entire IL-6 family. The functional activation relies on a hexameric complex consisting of two IL-6 molecules, two IL-6R units, and two gp130 units. This assembly triggers downstream intracellular signaling cascades, primarily the JAK-STAT3 pathway, as well as the MAPK and PI3K/Akt pathways.
IL-6 is a highly pleiotropic cytokine produced by monocytes, macrophages, T cells, and fibroblasts in response to infection or tissue injury. It serves as a principal coordinator of the acute-phase response. IL-6 targets hepatocytes in the liver to induce the rapid synthesis of acute-phase proteins like C-reactive protein (CRP), fibrinogen, and hepcidin (which drives iron sequestration, contributing to anemia of chronic disease). Concurrently, it reduces albumin production. Within the adaptive immune system, IL-6 drives the differentiation of B cells into antibody-producing plasma cells and promotes pro-inflammatoryTh17 cell polarization while suppressing regulatory T cells (Treg).
- Biomarker: Elevated serum levels of IL-6 serve as a vital clinical marker for evaluating severe systemic inflammation, sepsis, and cytokine release syndrome (CRS).
- Therapeutic Target: Pathological overexpression of IL-6 fuels chronic autoimmune disorders and malignancies. Consequently, monoclonal antibodies targeting the IL-6 receptor—such as Tocilizumab and Sarilumab—are heavily utilized to treat rheumatoid arthritis (RA), giant cell arteritis, systemic juvenile idiopathic arthritis, Castleman’s disease, and severe COVID-19 pneumonia.




Reviews
There are no reviews yet.